We have retained all of the commercial rights for the affimers and the testing. So, we’re going to continue our ongoing discussions wi9th other diagnostic companies with a view to establishing other partnerships to develop rapid tests, like the test strips, but also other forms of diagnostic test that can add to the overall testing capacity to fight this infection.